Securecell expands its market activities in Asia and Israel by cooperating with Shanghai based Alit Life Science, South Korea based Biofors Global and Rehovot based Danyel Biotech as partners for marketing and sales activities in China, Korea and Israel.
Securecell partnersp with Alit Life Science, Biofors Global and Danyel Biotech to build its market presence in China, Korea and Israel as a major step to further penetrate new markets.
“Alit, Biofors and Danyel were selected based on the strong connection and network within China, Korea and Israel biopharma market as well as the existing competence in selling high value products to bioprocessing industries. It is an excellent addition to our expanding worldwide network of marketing and sales partners addressing the needs of a growing and demanding biopharma business.” said Dr. Michele Bomio, CFO of Securecell.
Initially, the new partners will focus on distributing Lucullus PIMS software solution which has been Securecell’s flagship product for many years, as well as Numera autosampling and sample processing machine. In a second step, they will enrich their portfolio by adding Securecell’s new products tailored to improving perfusion cultures at the benchtop scale.
David Chen, founder of Alit Life Science commented: “We are very excited to cooperate with Securecell in China. I believe there is a big market for their advanced products, both the software system and the automation sampling machine. Today China is one of the biggest worldwide players in the biotech field. I believe this new cooperation will help Chinese customers to use innovative and world leading software engineering technology to improve their processes in R&D and production, thanks also to Securecell’s PAT system, which helps to supply better biotech medicaments to help the improvement of human health. Our team is looking forward to working with Securecell’s people in order to realize our marketing goal in China”.
Biofors CTO Keebung Rhee stated: “Not only Lucullus will be the perfect solution for Korean biotech players as a part of MES in Smart factory environments but also Numera will be very helpful for automated sampling of bioprocesses in biopharma companies. Smart factory, PAT, DoE and QbD are a big issue in recent manufacturing technology in Korea and Securecell products will dramatically contribute to enlarge and improve the process technology developments in our country”.
Luly Gurevich, CEO of Danyel Biotech, said: “This new partnership with Securecell helps us to deliver high-end technological solutions in the biopharmaceutical industry and biological research fields. Lucullus will enable much better control of our customers processes and having Numera will open new opportunities, along with our wide portfolio of instrumentation, media, supplements and consumables for Upstream.”